We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QRVO:NASDAQQorvo, Inc. Analysis

Data as of 2026-09-06 - not real-time

$102.84

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Qorvo, Inc. trades at $102.84, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. The last 30 days have gained 18.9%. Momentum indicators put RSI at 69.1 (approaching overbought) with MACD reading bullish. Recent trading has carved out support near $91.86 and resistance around $103.55.
Valuation screens as fair: a P/E of 23.9 sits below the sector average of 33.2. Analyst price targets sit 12.3% below the current price. Revenue is contracting at 4.2% on a 11.0% profit margin.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 31.7%, a beta of 1.22 and a maximum drawdown of 23.8%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 4 out of 10.

Top Market Events

Qorvo QRVO might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a...Communications chips maker Qorvo NASDAQ: QRVO reported Q2 CY2026 results beating Wall Street’s revenue expectations,...Antipodes Partners published its “Antipodes Global Strategy” second-quarter 2026 investor letter, highlighting the...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 87.83
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 23.9 versus sector average of 33.2
  • Trading above the 200-day average of 87.83

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • P/E of 23.9 versus sector average of 33.2
  • Analyst targets imply -12.3% versus the current price
  • Revenue contracting at -4.2%

Key Metrics & Analysis

Financial Health

Revenue Growth-4.20%
Profit Margin10.95%
P/E Ratio23.9
ROE11.56%
ROA6.71%
Debt/Equity44.62
P/B Ratio2.6
Op. Cash Flow$765.2M
Free Cash Flow$476.1M
Industry P/E33.2

Technical Analysis

TrendBullish
RSI69.1
Support$91.86
Resistance$103.55
MA 20$97.05
MA 50$92.21
MA 200$87.83
MACDBullish
VolumeStable
Fear & Greed Index95.48

Valuation

Fair Value$65.83
Target Price$90.17
Upside/Downside-12.32%
GradeFair
TypeBlend

Risk Assessment

Beta1.22
Volatility31.66%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.